share_log

12 Health Care Stocks Moving In Wednesday's After-Market Session

Benzinga ·  Oct 31 04:31

Gainers

  • Tenon Medical (NASDAQ:TNON) shares moved upwards by 28.8% to $4.2 during Wednesday's after-market session. The market value of their outstanding shares is at $2.3 million.
  • Alphatec Holdings (NASDAQ:ATEC) shares increased by 11.21% to $6.25. The market value of their outstanding shares is at $877.9 million. The company's, Q3 earnings came out today.
  • Estrella Immunopharma (NASDAQ:ESLA) stock rose 10.79% to $0.9. The market value of their outstanding shares is at $32.8 million.
  • Envista Holdings (NYSE:NVST) stock rose 9.2% to $21.0. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q3 earnings report came out today.
  • TFF Pharmaceuticals (NASDAQ:TFFP) stock moved upwards by 7.56% to $2.7. The market value of their outstanding shares is at $9.3 million.
  • Citius Oncology (NASDAQ:CTOR) stock moved upwards by 7.5% to $1.29. The company's market cap stands at $91.9 million.

Losers

  • Corcept Therapeutics (NASDAQ:CORT) shares fell 16.8% to $39.0 during Wednesday's after-market session. The company's market cap stands at $4.0 billion. The company's, Q3 earnings came out today.
  • Acadia Healthcare Co (NASDAQ:ACHC) shares decreased by 13.22% to $45.2. The company's market cap stands at $4.1 billion. The company's, Q3 earnings came out today.
  • Venus Concept (NASDAQ:VERO) stock decreased by 12.77% to $0.34. The company's market cap stands at $2.4 million.
  • CareMax (NASDAQ:CMAX) shares declined by 7.43% to $1.87. The market value of their outstanding shares is at $7.1 million.
  • Anixa Biosciences (NASDAQ:ANIX) stock decreased by 6.69% to $3.35. The company's market cap stands at $107.8 million.
  • Eledon Pharma (NASDAQ:ELDN) stock fell 6.31% to $3.93. The market value of their outstanding shares is at $162.4 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment